Literature DB >> 23999443

Targeting lactate metabolism for cancer therapeutics.

Joanne R Doherty1, John L Cleveland.   

Abstract

Lactate, once considered a waste product of glycolysis, has emerged as a critical regulator of cancer development, maintenance, and metastasis. Indeed, tumor lactate levels correlate with increased metastasis, tumor recurrence, and poor outcome. Lactate mediates cancer cell intrinsic effects on metabolism and has additional non-tumor cell autonomous effects that drive tumorigenesis. Tumor cells can metabolize lactate as an energy source and shuttle lactate to neighboring cancer cells, adjacent stroma, and vascular endothelial cells, which induces metabolic reprogramming. Lactate also plays roles in promoting tumor inflammation and in functioning as a signaling molecule that stimulates tumor angiogenesis. Here we review the mechanisms of lactate production and transport and highlight emerging evidence indicating that targeting lactate metabolism is a promising approach for cancer therapeutics.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23999443      PMCID: PMC3754272          DOI: 10.1172/JCI69741

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  106 in total

1.  Phase I/II study of AT-101 with topotecan in relapsed and refractory small cell lung cancer.

Authors:  Rebecca Suk Heist; Jerry Fain; Bernard Chinnasami; Waseem Khan; Julian R Molina; Lecia V Sequist; Jennifer S Temel; Panos Fidias; Valari Brainerd; Lance Leopold; Thomas J Lynch
Journal:  J Thorac Oncol       Date:  2010-10       Impact factor: 15.609

2.  Derepression of Polycomb targets during pancreatic organogenesis allows insulin-producing beta-cells to adopt a neural gene activity program.

Authors:  Joris van Arensbergen; Javier García-Hurtado; Ignasi Moran; Miguel Angel Maestro; Xiaobo Xu; Mark Van de Casteele; Anouchka L Skoudy; Matteo Palassini; Harry Heimberg; Jorge Ferrer
Journal:  Genome Res       Date:  2010-04-15       Impact factor: 9.043

3.  Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells.

Authors:  Ubaldo E Martinez-Outschoorn; Renee M Balliet; Dayana B Rivadeneira; Barbara Chiavarina; Stephanos Pavlides; Chenguang Wang; Diana Whitaker-Menezes; Kristin M Daumer; Zhao Lin; Agnieszka K Witkiewicz; Neal Flomenberg; Anthony Howell; Richard G Pestell; Erik S Knudsen; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2010-08-28       Impact factor: 4.534

Review 4.  Understanding the "lethal" drivers of tumor-stroma co-evolution: emerging role(s) for hypoxia, oxidative stress and autophagy/mitophagy in the tumor micro-environment.

Authors:  Michael P Lisanti; Ubaldo E Martinez-Outschoorn; Barbara Chiavarina; Stephanos Pavlides; Diana Whitaker-Menezes; Aristotelis Tsirigos; Agnieszka Witkiewicz; Zhao Lin; Renee Balliet; Anthony Howell; Federica Sotgia
Journal:  Cancer Biol Ther       Date:  2010-09-19       Impact factor: 4.742

5.  IL-23-dependent and -independent enhancement pathways of IL-17A production by lactic acid.

Authors:  Masahiko Yabu; Hiroaki Shime; Hiromitsu Hara; Takashi Saito; Misako Matsumoto; Tsukasa Seya; Takashi Akazawa; Norimitsu Inoue
Journal:  Int Immunol       Date:  2010-12-03       Impact factor: 4.823

6.  Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression.

Authors:  Anne Le; Charles R Cooper; Arvin M Gouw; Ramani Dinavahi; Anirban Maitra; Lorraine M Deck; Robert E Royer; David L Vander Jagt; Gregg L Semenza; Chi V Dang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-19       Impact factor: 11.205

7.  Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma.

Authors:  Céline Pinheiro; André Albergaria; Joana Paredes; Bárbara Sousa; Rozany Dufloth; Daniella Vieira; Fernando Schmitt; Fátima Baltazar
Journal:  Histopathology       Date:  2010-06       Impact factor: 5.087

8.  The inhibition of monocarboxylate transporter 2 (MCT2) by AR-C155858 is modulated by the associated ancillary protein.

Authors:  Matthew J Ovens; Christine Manoharan; Marieangela C Wilson; Clarey M Murray; Andrew P Halestrap
Journal:  Biochem J       Date:  2010-10-15       Impact factor: 3.857

Review 9.  Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer.

Authors:  R J DeBerardinis; T Cheng
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

10.  Hypoxia stimulates lactate release and modulates monocarboxylate transporter (MCT1, MCT2, and MCT4) expression in human adipocytes.

Authors:  Fátima Pérez de Heredia; I Stuart Wood; Paul Trayhurn
Journal:  Pflugers Arch       Date:  2009-10-30       Impact factor: 3.657

View more
  346 in total

1.  Exploiting tumor metabolism: challenges for clinical translation.

Authors:  Matthew G Vander Heiden
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

2.  H2S-induced S-sulfhydration of lactate dehydrogenase a (LDHA) stimulates cellular bioenergetics in HCT116 colon cancer cells.

Authors:  Ashley A Untereiner; Gabor Oláh; Katalin Módis; Mark R Hellmich; Csaba Szabo
Journal:  Biochem Pharmacol       Date:  2017-04-09       Impact factor: 5.858

Review 3.  Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?

Authors:  Nissim Hay
Journal:  Nat Rev Cancer       Date:  2016-09-16       Impact factor: 60.716

4.  Microfluidic Platform for the Isolation of Cancer-Cell Subpopulations Based on Single-Cell Glycolysis.

Authors:  Claudia Zielke; Ching W Pan; Adriana J Gutierrez Ramirez; Cameron Feit; Chandler Dobson; Catherine Davidson; Brody Sandel; Paul Abbyad
Journal:  Anal Chem       Date:  2020-04-30       Impact factor: 6.986

5.  Shikonin, vitamin K3 and vitamin K5 inhibit multiple glycolytic enzymes in MCF-7 cells.

Authors:  Jing Chen; Xun Hu; Jingjie Cui
Journal:  Oncol Lett       Date:  2018-03-13       Impact factor: 2.967

Review 6.  VDAC Regulation: A Mitochondrial Target to Stop Cell Proliferation.

Authors:  Diana Fang; Eduardo N Maldonado
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

7.  Effects of a monocarboxylate transport 1 inhibitor, AZD3965, on retinal and visual function in the rat.

Authors:  Annette E Allen; Elizabeth A Martin; Katherine Greenwood; Claire Grant; Peter Vince; Robert J Lucas; William S Redfern
Journal:  Br J Pharmacol       Date:  2020-09-13       Impact factor: 8.739

Review 8.  Heterogeneity of glycolysis in cancers and therapeutic opportunities.

Authors:  Marc O Warmoes; Jason W Locasale
Journal:  Biochem Pharmacol       Date:  2014-08-02       Impact factor: 5.858

9.  Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis.

Authors:  Na Xie; Zheng Tan; Sami Banerjee; Huachun Cui; Jing Ge; Rui-Ming Liu; Karen Bernard; Victor J Thannickal; Gang Liu
Journal:  Am J Respir Crit Care Med       Date:  2015-12-15       Impact factor: 21.405

10.  Parathyroid Hormone-Related Peptide-Linked Hypercalcemia in a Melanoma Patient Treated With Ipilimumab: Hormone Source and Clinical and Metabolic Correlates.

Authors:  Teresa Anne Mills; Marlana Orloff; Marina Domingo-Vidal; Paolo Cotzia; Ruth C Birbe; Rossitza Draganova-Tacheva; Maria P Martinez Cantarin; Madalina Tuluc; Ubaldo Martinez-Outschoorn
Journal:  Semin Oncol       Date:  2015-09-08       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.